A detailed history of Fmr LLC transactions in Uni Qure N.V. stock. As of the latest transaction made, Fmr LLC holds 4,298 shares of QURE stock, worth $24,756. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,298
Previous 28,806 85.08%
Holding current value
$24,756
Previous $149,000 87.25%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$4.39 - $5.43 $107,590 - $133,078
-24,508 Reduced 85.08%
4,298 $19,000
Q1 2024

May 13, 2024

SELL
$4.82 - $6.93 $96,284 - $138,433
-19,976 Reduced 40.95%
28,806 $149,000
Q4 2023

Feb 13, 2024

SELL
$5.63 - $8.27 $829,625 - $1.22 Million
-147,358 Reduced 75.13%
48,782 $330,000
Q3 2023

Nov 13, 2023

SELL
$6.71 - $11.83 $15.2 Million - $26.8 Million
-2,265,378 Reduced 92.03%
196,140 $1.32 Million
Q2 2023

Aug 11, 2023

SELL
$11.12 - $22.2 $2.6 Million - $5.2 Million
-234,153 Reduced 8.69%
2,461,518 $28.2 Million
Q1 2023

May 11, 2023

SELL
$18.7 - $23.07 $98,287 - $121,255
-5,256 Reduced 0.19%
2,695,671 $54.3 Million
Q4 2022

Feb 13, 2023

SELL
$18.12 - $27.32 $431,799 - $651,035
-23,830 Reduced 0.87%
2,700,927 $61.2 Million
Q3 2022

Nov 10, 2022

SELL
$16.98 - $25.54 $1.05 Million - $1.58 Million
-61,926 Reduced 2.22%
2,724,757 $51.1 Million
Q2 2022

Aug 12, 2022

SELL
$13.15 - $20.45 $13.2 Million - $20.6 Million
-1,006,781 Reduced 26.54%
2,786,683 $51.9 Million
Q1 2022

May 13, 2022

SELL
$14.54 - $21.5 $7.95 Million - $11.8 Million
-546,599 Reduced 12.59%
3,793,464 $68.5 Million
Q4 2021

Feb 14, 2022

SELL
$20.24 - $36.01 $955,327 - $1.7 Million
-47,200 Reduced 1.08%
4,340,063 $90 Million
Q3 2021

Nov 15, 2021

SELL
$26.01 - $38.22 $680,967 - $1 Million
-26,181 Reduced 0.59%
4,387,263 $140 Million
Q2 2021

Aug 13, 2021

BUY
$29.97 - $37.17 $132 Million - $164 Million
4,413,444 New
4,413,444 $136 Million

Others Institutions Holding QURE

About uniQure N.V.


  • Ticker QURE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,729,100
  • Market Cap $269M
  • Description
  • uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...
More about QURE
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.